Healthcare
Starr invests China's Top Grade Healthcare
Starr International Company, a privately-held global financial services group, has made a $40 million investment in Top Grade Healthcare Ltd., a provider of diagnostic imaging equipment and hospital management services in China.
CHAMP seeks buyers for Healthcare Australia
In the latest Australian healthcare sector deal, local PE firm CHAMP Private Equity is reportedly looking to sell Healthcare Australia, the country’s largest nursing, homecare and medical specialist placement company, worth an estimated $265 million....
Carlyle, TPG pick up Healthscope for $1.73 billion
The Carlyle Group and TPG Capital have won out in a bidding contest for Australian private hospitals and pathology services operator Healthscope Ltd., with an A$1.99 billion ($1.73 billion) all-cash offer that has already been unanimously recommended...
ACA takes 10% of listed drug store chain in Japan
ACA Inc., a Tokyo-based private equity firm with special focus on healthcare and media, has taken a 10% stake through a PIPE investment in Create SD Holdings, a drug store chain operator, for approximately $50 million.
Baring India investee PharmaARC could seek fresh funds
PharmaARC Analytics Solutions, a healthcare BPO company invested by Baring Private Equity India, may be seeking further investment - a move that contradicts Baring, which has stated that it has neither plans to exit its 10% stake nor commitment to inject...
Khazanah may boost Parkway offer to beat Fortis
Following an offer by Malaysian sovereign wealth fund Khazanah Nasional to take a 51.5% stake in Singapore-based hospital group Parkway Holdings for $835 million, or S$3.78 ($2.75) a share, Khazanah is considering offering S$4.00 ($2.90) a share in order...
Carlyle, TPG wrap up Healthscope for $1.73 billion
The Carlyle Group and TPG Capital have successfully concluded their bid for Australia's Healthscope with a A$1.99 billion ($1.73 billion) all-cash offer, well above previous expectations, in the biggest Australian private equity deal since 2007.
Final Healthscope bids confirmed by Carlyle, TPG as Blackstone withdraws
The Jul 16th deadline for bids on Australian private hospital and pathology operator Healthscope saw the Carlyle Group and TPG Capital confirm that they had submitted bids for the asset, despite the withdrawal of Blackstone Group from their consortium...
CCBI Healthcare Fund makes two investments
CCB International, the investment arm of China Construction Bank, has made two investments in the medical sector, including an RMB150 million ($36.9 million) capital injection into Luyan, a medical company in Fujian, and an RMB100 million ($14.7 million)...
Norwest leads $7.2 million fundraising round for Perfint Healthcare
Norwest Venture Partners has led a $7.2 million Series B fundraising round for Indian medical equipment developer Perfint Healthcare Pvt Ltd. with Perfint’s existing investors Accel Partners and IDG Ventures also participating in the financing.
Allied Medical talks complicate Healthscope situation
The $1.6 billion takeover bid for Australian private hospital and pathology operator Healthscope by a consortium of the Blackstone Group, the Carlyle Group, and TPG Capital, with a rival bid from Kohlberg Kravis Roberts & Co., has been complicated by...
Lombard targets Philippines healthcare with The Medical City
Veteran Asian investment firm Lombard Investments has announced a follow-on investment into The Medical City, a market-leading private healthcare group in the Philippines, for an undisclosed amount.
Khazanah extends Parkway bid
Malaysian SWF Khazanah Nasional has extended its partial offer for a control stake in Singapore-based hospital group Parkway Holdings to July 26th, a moves that comes as it repositions itself after fellow Parkway stakeholder and rival bidder Fortis Group...
Milestone Religare on track for $200 million raise
Milestone Religare Investment Advisors, the private equity JV between local fund house Milestone Capital and financial services group Religare Enterprises, is on track to launch its $200 million India Build-Out Fund II, with discussions already commenced...
Blackstone takes China Animal stake
The Blackstone Group has made a commitment giving it exposure to China's foods and agriculture and healthcare sectors, by leading a significant minority investment in Singapore-listed China Animal Healthcare, a maker of animal drugs and vaccines, for...
Parkway Holdings playing hardball
The leading contenders to take majority control of Singaporean hospital management firm Parkway Holdings Ltd. have separately experienced hurdles in their quest to obtain their acquisition target, extending the highly contested race that began in March....
ICICI may exit I-Ven Pharma to Dr. Reddy's Labs
ICICI Venture is reportedly considering selling its 100% stake in I-Ven Pharma Capital Ltd. to its partner Dr. Reddy's Labs (DRL), which would be the latest in a string of exits by the Indian private equity firm.
ICICI exits Metropolis Healthcare after Warburg Pincus investment
ICICI Venture is to fully divest from India’s Metropolis Healthcare Ltd., following Warburg Pincus’s move to inject $85 million into the laboratories chain.
KKR nixes CVC partnership on Healthscope
Kohlberg Kravis Roberts & Co. has said that CVC Capital Partners will not be participating in a bid for Australia's Healthscope, estimated at potentially up to A$1.84 billion ($1.56 billion), with KKR continuing on the bid by itself.
Khazanah Parkway bid "not compelling"
Singapore’s Parkway Holdings Ltd., Asia’s largest publicly listed hospital-management firm and former TPG Capital investee, has released its response to Khazanah Nasional Bhd.’s acquisition bid, saying that its financial advisor Morgan Stanley has found...
Blackstone could exit Emcure
The Blackstone Group may be on the verge of exiting its first investment in India, Emcure Pharmaceuticals, following earlier reports that Kohlberg Kravis Roberts & Co. may be about to commit $50 million to the company - the same amount as Blackstone's...
SBI in new round for Quark Pharmaceuticals
Japan's SBI Holdings Group, the investment conglomerate behind the SoftBank family of funds, has made a further commitment of $10 million to investee company Quark Pharmaceuticals, a Californian developer of RNAi-based drugs.
Mizuho Capital to take over Medical Tribune
Japan's Mizuho Capital Partners, the MBO-focused buyout firm 50:50 owned by Mizuho Corporate Bank and its managing principals, will pay JPY5.3 billion ($58 million) to acquire Medical Tribune, a publisher of weekly medical newspapers, from listed Japanese...
Qiming launches RMB fund for biomedical investments
Chinese VC firm Qiming Venture Partners has launched an RMB250 million ($36.6 million) fund, focusing particularly on biomedical sector-related investments.